Fortress Biotech, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Fortress Biotech, Inc. (FBIO) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-31
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $400.00K 10-K · filed 2026-03-31 | $1.00M 10-K · filed 2025-03-31 |
| 2024-09-30 | $600.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $600.00K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $400.00M 10-Q · filed 2025-05-15 | $400.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 | |
| 2023-09-30 | $400.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $600.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $100.00K 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 | |
| 2019-12-31 | $11.90M 10-K · filed 2020-03-16 | |
| 2018-12-31 | $6.10M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $4.10M 10-K · filed 2017-03-16 | |
| 2016-09-30 | $16.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $33.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $62.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $100.00K 10-K · filed 2016-03-15 | |
| 2015-09-30 | $100.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $700.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $900.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.20M 10-K · filed 2015-03-16 | |
| 2014-09-30 | $1.50M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.90M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $2.40M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $3.40M 10-K · filed 2014-03-14 | |
| 2013-09-30 | $9.10M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $10.60M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $10.70M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $4.40M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |